期刊文献+

蛋白酶体抑制剂处理神经细胞系后Nicastrin的表达变化及其与Aβ的关系 被引量:1

Expression change of Nicastrin in the neuronal cells and its relationship with Aβ generation after proteasomal inhibitor treatment
下载PDF
导出
摘要 目的探讨蛋白酶体抑制剂处理后神经细胞内Nicastrin(NCT)的表达变化,及其与γ-分泌酶活性和Aβ生成的关系。方法运用亚细胞器分级分离技术、免疫共沉淀、Western blot和ELISA等检测神经细胞内NCT的表达及Aβ水平。结果正常情况下NCT主要分布于内质网和高尔基复合体,极少量分布于溶酶体,蛋白酶体抑制剂Lac-tacystin处理后NCT水平升高(P<0.001),且细胞内增多的NCT也主要聚集在内质网和高尔基复合体;NCT与泛素在细胞内共存;NCT的蛋白降解不受PS的影响;NCT降解受阻可引起细胞内γ-分泌酶的底物C99、C83显著减少,而γ-分泌酶的产物Aβ40、Aβ42的生成显著增多(P<0.01)。结论 NCT的降解可通过泛素-蛋白酶体途径实现,蛋白酶体抑制剂处理后神经细胞内NCT水平升高,且增多的NCT可促进APP的代谢及Aβ的生成。 Objective To explore whether Nicastrin undergoes ubiquitination before proteasomal degradation,as well as the relationship between Nicastrin protein level and Aβ generation.Methods Cell fractionation,Western blot,immunoprecipitation as well as ELISA were used to check the expression of NCT and Aβ level.Results NCT distributes primarily in ER and Golgi apparatus but less in lysosome.Increased NCT accumulates was found in the ER and Golgi apparatus after proteasomal inhibition.NCT and ubiquitin colocalized and interacted with each other in cells.The degradation of NCT was not affected by PS.Overexpression of NCT by transient NCT plasmid transfection or inhibition of NCT proteasomal degradation can decrease substrate of γ-secretase,C99 and C83,and increase production of γ-secretase,Aβ40 and Aβ42(P0.01).Conclusion The degradation of NCT is resulted from ubiquitin-proteasome pathway.The expression of NCT is increased following proteasomal inhibition,and over-expression of NCT facilitates APP processing and Aβ generation.
出处 《基础医学与临床》 CSCD 北大核心 2011年第5期475-479,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(30700885) 教育部重点项目(209102) 重庆市首届优秀人才资助计划(渝教人[2009]2号) 重庆市教委资助计划(KJ090328)
关键词 NICASTRIN 蛋白酶体抑制剂 泛素化修饰 Γ-分泌酶 Nicastrin proteasomal inhibitor ubiquitination γ-secretase
  • 相关文献

参考文献11

  • 1De Strooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precur- sor protein [J]. Nature, 1998, 391:387-390.
  • 2Tolia A, De Strooper B. Structure and function of γ-secre- tase [J]. Semin Cell Dev Biol, 2009, 20:211 -218.
  • 3Yu G, Nishimura M, Arawaka S, et al. Nicastrin modu- lates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing [ J ]. Nature, 2000, 407:48 - 54.
  • 4骆世芳,龙志敏,高宝兵,汪克建,贺桂琼.蛋白酶体抑制剂对神经细胞nicastrin表达的影响[J].中国病理生理杂志,2010,26(6):1085-1090. 被引量:3
  • 5Oddo S. The ubiquitin-proteasome system in Alzheimer's disease [J]. J Cell Mol Med, 2008, 12:363 -373.
  • 6Golab J, Bauer TM, Daniel V, et al: Role of the ubiquitin- proteasome pathway in the diagnosis of human diseases[ J]. Clin Chem Acta, 2004, 340 : 27 - 40.
  • 7Oh S, Hong HS, Hwang E, et al. Amyloid peptide attenu-ates the proteasome activity in neuronal ceils [ J ]. Mech Ageing Dev, 2005, 126: 1292- 1299.
  • 8Billings LM, Oddo S, Green KN, et al. Intraneuronal Abe- ta causes the onset of early Alzheimer's disease-related cog- nitive deficits in transgenic mice [ J]. Neuron, 2005, 45 : 675 - 688.
  • 9Zhang YW, Luo WJ, Wang H, et al. Nicastrin is critical for stabihty and trafficking but not association of other pre- senilin/gamma-secretase components [ J ]. J Biol Chem, 2005, 280 : 17020 - 17026.
  • 10Berezovska O, Ramdya P, Skoch J, et al. Amyloid pre- cursor protein associates with a Nicastrin-dependent doc- king site on the presenilin 1-γ-secretase complex in cells demonstrated by fluoresence lifetime imaging [ J ]. J Neu- rosci, 2003, 23 : 4560 - 4566.

二级参考文献19

  • 1Dries DR,Yu G.Assembly,maturation,and trafficking of the gamma-secretase complex in Alzheimer's disease[J].Curr Alzheimer Res,2008,5(2):132-146.
  • 2Yu G,Nishimura M,Arawaka S,et al.Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta APP processing[J].Nature,2000,407(6800):48-54.
  • 3Tolia A,De Strooper B.Structure and function of γ-secretase[J].Semin Cell Dev Biol,2009,20(2):211-218.
  • 4Kimberly WT,LaVoie MJ,Ostaszewski BL,et al.Gamma-secretase is a membrane protein complex comprised of presenilin,nicastrin,Aph-1,and Pen-2[J].Proc Natl Acad Sci USA,2003,100(11):6382-6387.
  • 5Confaloni A,Crestini A,Albani D,et al.Rat nicastrin gene:cDNA isolation,mRNA variants and expression pattern analysis[J].Brain Res Mol Brain Res,2005,136(1-2):12-22.
  • 6Zhang YW,Luo WJ,Wang H,et al.Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components[J].J Biol Chem,2005,280(17):17020-17026.
  • 7Shah S,Lee SF,Tabuchi K,et al.Nicastrin functions as a gamma-secretase-substrate receptor[J].Cell,2005,122(3):435-447.
  • 8De Vrij FM,Sluijs JA,Gregori L,et al.Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death[J].Faseb J,2001,15(14):2680-2688.
  • 9Keller JN,Hanni KB,Markesbery WR.Impaired proteasome function in Alzheimer's disease[J].J Neurochem,2000,75(1):436-439.
  • 10Golab J,Bauer TM,Daniel V,et al.Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases[J].Clin Chem Acta,2004,340(1-2):27-40.

共引文献2

同被引文献10

  • 1Tisdale MJ. Mechanisms of cancer cachexia [ J ]. Physiol Rev ,2009,89:381 - 410.
  • 2Dodson S, Baracos VE, .latoi A, et al. Muscle wasting in cancer cachexia : clinical implications, diagnosis, and emer- ging treatment strategies [ J]. Annu Rev Med, 2011,62- 265 - 279.
  • 3Paul PK, Bhatnagar S, Mishra V, et al. The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-lnduced Skeletal Muscle Atrophy through Multiple Mechanisms [ J ]. Mol Cell Bio1,2012,32 :1248 - 1259.
  • 4Kumar A, Bhatnagar S, Paul PK. TWEAK and TRAF6 regu- late skeletal muscle atrophy[ J]. Curr Opin Clin Nutr Metab Care ,2012,15:233 - 239.
  • 5Paul PK, Gupta SK, Bhatnagar S, et al. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice[ J]. J Cell Biol,2010,191 : 1395 - 1411.
  • 6Sandri M. Autophagy in skeletal muscle [ J ]. FEBS Lett,2010,584:1411 -1416.
  • 7Melstrom LG, Melstrom KA Jr, Ding XZ,et al. Mechanisms of skeletal muscle degradation and its therapy in cancer ca- chexia[ J ]. Histol Histopatho1,2007,22 : 805 - 814.
  • 8Xu G, Wen H, Zhou H, et al. Involvement of IRAKs and TRAFs in antiq32 GP/Zβ2 GPl-induced tissue factor expres- sion in THP-1 ceils [ J]. Thromb Haemost, 2011, 106: 1158 - 1169.
  • 9Fearon K,Strasser F,Anker SD,et al. Definition and classi- fication of cancer cachexia: an international consensus[J]. Lancet Oncol,2011,12:489 -495.
  • 10张文,张炬,曾小峰,等.TRAF6在B淋巴瘤细胞系NF-κB和AP-1信号传导通路中的作用[J].基础跃学与临床,2009,29,716-720.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部